No black box warning on record for Jevtana

As of the latest FDA labeling reviewed, Jevtana (CABAZITAXEL) does not carry a black box warning. Standard warnings and precautions still apply — see the full Jevtana medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Bone marrow suppression (particularly neutropenia) and its clinical consequences (febrile neutropenia, neutropenic infections, and death): Monitor blood counts frequently to determine if dosage modification or initiation of G-CSF is needed. Closely monitor patients with hemoglobin <10 g/dL. ( 2.2 , 4 , 5.1 ) Increased toxicities in elderly patients: Patients ≥65 years of

No black box warning on record for Jevtana

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Bone marrow suppression (particularly neutropenia) and its clinical consequences (febrile neutropenia, neutropenic infections, and death): Monitor blood counts frequently to determine if dosage modification or initiation of G-CSF is needed. Closely monitor patients with hemoglobin <10 g/dL. ( 2.2 , 4 , 5.1 ) Increased toxicities in elderly patients: Patients ≥65 years of

Jevtana Black Box Warning

No black box warning on record for Jevtana

Other warnings & precautions

Jevtana Black Box Warning

No black box warning on record for Jevtana

Other warnings & precautions